Management of Bleeding After Fibrinolysis

Pharmacological Management

• For severe, uncontrolled bleeding, the American Heart Association recommends considering antifibrinolytic agents, such as tranexamic acid: 1000 mg IV infused over 10 minutes, or ε-aminocaproic acid: 4-5 g over 1 hour, followed by 1 g IV until bleeding is controlled 1

Special Considerations

• The American College of Cardiology notes that very early catheterization (within 2-3 hours) after fibrinolytic therapy carries an increased bleeding risk and should be avoided unless necessary for failed fibrinolysis 2
• The American Heart Association guidelines indicate that bleeding risk is higher in elderly patients and those with renal impairment 4

Prevention Strategies for Future Procedures

• The European Society of Cardiology suggests considering radial artery access rather than femoral access for subsequent procedures to reduce bleeding risk 5
• Patient-specific risk factors for bleeding should be considered before administering fibrinolytics, according to the European Heart Journal 4